SYNTHETIC PEPTIDES FROM THE PRINCIPAL NEUTRALIZING DOMAIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) ENHANCE HIV-1 INFECTION THROUGH A CD4-DEPENDENT MECHANISM